SR | Antipsychotic exposure is an independent risk factor for breast cancer

Antipsychotic exposure is an independent risk factor for breast cancer: A systematic review of epidemiological evidence – Frontiers in Oncology

Related: Large observational study suggests prolactin-increasing antipsychotics are associated with increased risk of breast cancer (OR=1.56 for over 5 years of exposure); prolactin-sparing antipsychotics (including clozapine, quetiapine, or aripiprazole), on the other hand, were not associated with increased risk.